Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Vebreltinib
2. 1440964-89-5
3. Plb-1001
4. Apl-101
5. Vebreltinib [usan]
6. Cbi-3103
7. 2wzp8a9vfn
8. Cbt-101
9. 6-(1-cyclopropylpyrazol-4-yl)-3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazine
10. 1,2,4-triazolo(4,3-b)pyridazine, 6-(1-cyclopropyl-1h-pyrazol-4-yl)-3-(difluoro(6- Fluoro-2-methyl-2h-indazol-5-yl)methyl)-
11. 6-(1-cyclopropyl-1h-pyrazol-4-yl)-3-(difluoro(6-fluoro-2-methyl-2h-indazol-5- Yl)methyl)-1,2,4-triazolo(4,3-b)pyridazine
12. Unii-2wzp8a9vfn
13. Vebreltinib [inn]
14. Bozitinib (plb-1001)
15. Vebreltinib [who-dd]
16. Chembl4650443
17. Schembl15594471
18. Gtpl11677
19. Plb1001
20. Bdbm107096
21. Ex-a5644
22. S6762
23. Who 11677
24. Hy-125017
25. Cs-0088607
26. Us9695175, 44
27. A937089
28. Plb-1001;t-101; Apl-101; Cbi-3103
29. 6-(1-cyclopropyl-1h-pyrazol-4-yl)-3-(difluoro(6-fluoro-2-methyl-2h-indazol-5-yl)methyl)-[1,2,4]triazolo[4,3-b]pyridazine
Molecular Weight | 424.4 g/mol |
---|---|
Molecular Formula | C20H15F3N8 |
XLogP3 | 2.1 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 4 |
Exact Mass | 424.13717700 g/mol |
Monoisotopic Mass | 424.13717700 g/mol |
Topological Polar Surface Area | 78.7 Ų |
Heavy Atom Count | 31 |
Formal Charge | 0 |
Complexity | 681 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
51
PharmaCompass offers a list of Vebreltinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Vebreltinib manufacturer or Vebreltinib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Vebreltinib manufacturer or Vebreltinib supplier.
PharmaCompass also assists you with knowing the Vebreltinib API Price utilized in the formulation of products. Vebreltinib API Price is not always fixed or binding as the Vebreltinib Price is obtained through a variety of data sources. The Vebreltinib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Vebreltinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vebreltinib, including repackagers and relabelers. The FDA regulates Vebreltinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vebreltinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Vebreltinib supplier is an individual or a company that provides Vebreltinib active pharmaceutical ingredient (API) or Vebreltinib finished formulations upon request. The Vebreltinib suppliers may include Vebreltinib API manufacturers, exporters, distributors and traders.
Vebreltinib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Vebreltinib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Vebreltinib GMP manufacturer or Vebreltinib GMP API supplier for your needs.
A Vebreltinib CoA (Certificate of Analysis) is a formal document that attests to Vebreltinib's compliance with Vebreltinib specifications and serves as a tool for batch-level quality control.
Vebreltinib CoA mostly includes findings from lab analyses of a specific batch. For each Vebreltinib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Vebreltinib may be tested according to a variety of international standards, such as European Pharmacopoeia (Vebreltinib EP), Vebreltinib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Vebreltinib USP).